Outcome of Patients Treated by Intravitreal Injections During the COVID-19 Lockdown: An Institutional Experience

Sukkarieh, Georges; Bonnin, Sophie; Azar, Georges; Lafolie, Justine; Alonso, Anne-Sophie; Erol, Ozlem; Pineau, Justine; Villain, Hélène; Guillaume, Jessica; Auge, Emmanuel; Mingou, Alain; Lejoyeux, Raphaël; Vasseur, Vivien; Mauget‐Faÿsse, Martine

doi:10.1080/02713683.2023.2200564

Cited by 1 publication

(3 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, this is considerably lower than previous retrospective reports from lockdown countries that found reductions in the number of treated patients of between 40% and 92% during the first months of the pandemic. 11–13 Sukkarieh et al 14 prospectively investigated the 1-year outcome of patients receiving intravitreal injections for retinal diseases during the pandemic in a country with a lockdown policy. They found that only 17% of the planned appointments were missed.…”

Section: Discussionmentioning

confidence: 99%

“…Missed visits may be due to cancellation of appointments by the hospital or fear of virus exposure. 14 The reduced willingness to seek medical care may be due to public transport limitations or fear of virus exposure during transportation or at the hospital. It is important to address these concerns and to increase the willingness to seek medical care.…”

Section: Discussionmentioning

confidence: 99%

“…There have been several previous publications on patient outcomes worldwide during the pandemic. 4,6,8,11–14 However, this is the first report from a setting without a lockdown, thereby providing valuable insights into the effects of the pandemic on ophthalmologic health care under these unique circumstances.…”

mentioning

confidence: 95%

See 2 more Smart Citations

Retinal vein occlusions before and during the COVID-19 pandemic. Visual outcomes and treatment patterns in a country with no mandatory lockdown.

Farrell,

Epstein

2024

Retina

View full text Add to dashboard Cite

Purpose: To investigate the incidence, treatment patterns and visual outcomes in patients with branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) before and during the COVID-19 pandemic in a country with no mandatory lockdown. Methods: This retrospective study included 788 patients presenting with a retinal vein occlusion (RVO) during 2019–2022 at St. Erik Eye Hospital. The control group and study groups consisted of patients presenting before and during the pandemic respectively. Results: The incidence of diagnosed RVO cases decreased from 281 patients before the pandemic to 236 patients during the first year of the pandemic (p<0.05). In BRVO patients at the end of follow-up, the best-corrected visual acuity (BCVA) improved 10.3 letters (95% CI 7.6-12.9) in the control group compared to 14.3 letters (95% CI 12.6-16.0) in the study groups (p<0.05). In CRVO patients the BCVA improved 6.3 letters (95% CI 2.7-10.0) in the control group compared to 8.6 letters (95% CI 5.7-11.4) in the study groups (p=NS). Overall, the number of intravitreal anti-vascular endothelial growth factor (VEGF) injections increased from 7.0 (95% CI 6.6-7.3) in the control group to 7.6 (95% CI 7.4-7.8) in the study groups (p<0.05). Conclusion: Good visual and anatomical outcomes were sustained, and the number of intravitreal anti-VEGF injections increased significantly in RVO patients during the COVID-19 pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%